ECO Animal Health Group’s (EAH) “Buy” Rating Reiterated at Shore Capital

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reissued by research analysts at Shore Capital in a report issued on Monday,Digital Look reports. They presently have a GBX 150 target price on the stock. Shore Capital’s price objective would indicate a potential upside of 70.19% from the stock’s current price.

ECO Animal Health Group Stock Performance

LON:EAH opened at GBX 88.14 on Monday. The company has a 50-day moving average of GBX 84.31 and a 200-day moving average of GBX 72.98. The firm has a market cap of £59.48 million, a price-to-earnings ratio of 36.27 and a beta of -0.05. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. ECO Animal Health Group has a twelve month low of GBX 50 and a twelve month high of GBX 100.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.